Di Nuzzo Private Wealth, Inc. Exact Sciences Corp Transaction History
Di Nuzzo Private Wealth, Inc.
- $658 Million
- Q2 2025
A detailed history of Di Nuzzo Private Wealth, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, Di Nuzzo Private Wealth, Inc. holds 19 shares of EXAS stock, worth $820. This represents 0.0% of its overall portfolio holdings.
Number of Shares
19
Previous 11
72.73%
Holding current value
$820
Previous $0
Infinity%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding EXAS
# of Institutions
644Shares Held
157MCall Options Held
1.64MPut Options Held
1.5M-
Capital World Investors Los Angeles, CA17.8MShares$770 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA17.6MShares$761 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA12.5MShares$540 Million0.11% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$521 Million0.01% of portfolio
-
State Street Corp Boston, MA6.61MShares$285 Million0.01% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $7.64B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...